Activation of the renin-angiotensin system (RAS) is implicated in most forms of kidney injury, and inhibiting its main effector, angiotensin II (Ang II), remains a cornerstone of therapy for progressive CKD [7], [8]. The gene discussed is REN; the disease is chronic kidney disease.